Haliton Alves de Oliveira

Guidelines for the pharmacological treatment of COVID-19. The task force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology

Maicon Falavigna, Verônica Colpani, Cinara Stein et al. · Revista Brasileira de Terapia Intensiva · 2020 · 120 citations · Full text

Medicine, Infectious Diseases, Pharmacology +7

7-Chloroquinolinotriazoles: Synthesis by the azide–alkyne cycloaddition click chemistry, antimalarial activity, cytotoxicity and SAR studies

Guilherme Rocha Pereira, Geraldo Célio Brandão, Lucas M. Arantes et al. · European Journal of Medicinal Chemistry · 2013 · 57 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial

Álvaro Avezum, Gustavo B.F. Oliveira, Haliton Alves de Oliveira et al. · The Lancet Regional Health - Americas · 2022 · 43 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial

Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menezes Neves et al. · EClinicalMedicine · 2023 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System

Jéssica Barreto Ribeiro dos Santos, Alessandra Maciel Almeida, Francisco de Assis Acúrcio et al. · Journal of Comparative Effectiveness Research · 2016 · 15 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15